Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 15;14(1):2047144. doi: 10.1080/19420862.2022.2047144

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.

This is an Open Access article that has been identified as being free of known restrictions under copyright law, including all related and neighbouring rights (https://creativecommons.org/publicdomain/mark/1.0/). You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.

PMC Copyright notice

Figure 1. — Molecular basis of SARS-CoV-2 spike recognition by NIH-CoVnb-112. (a) Crystal structure of NIH-CoVnb-112:SARS-CoV-2 RBD complex. The framework of NIH-CoVnb-112 is shown as yellow ribbons with the CDR1, CDR2, CDR3 colored green, Orange and pink, respectively. The SARS-CoV-2 RBD is colored blue. (b) Comparison of the RBD-contact footprint of NIH-CoVnb-112 and ACE2. The contact surface area is indicated by yellow and green lines for NIH-CoVnb-112 and ACE2, respectively, over the molecular surface of RBD. The electrostatic potential is displayed over the RBD surface and colored for negative (red), positive (blue), and neutral (white) electrostatic potential, respectively. (c) Enlarged view into the NIH-CoVnb-112:RBD interface. NIH-CoVnb-112 is shown as a ribbon with the same color scheme as (a) and the SARS-CoV-2 RBD is displayed as an electrostatic potential surface. (d) The interaction network at the NIH-CoVnb-112:RBD interface. The individual nanobody:RBD contacts are shown as lines with the diagram of buried surface area for individual interface residue shown on the sides. Hydrogen bonds and π -π stacking interactions are shown as blue and green lines, respectively. The ACE2 contact residues within the nanobody epitope are highlighted in red. The RBD mutations for SARS-CoV-2 variants are denoted in dark red with the Omicron mutations underlined. (e) Orthogonal views of the interaction network between NIH-CoVnb-112 and RBD. CDR residues are colored as in (a) and the RBD residues are colored in blue. Hydrogen bonds and salt bridges are denoted as yellow and black broken lines, respectively. (f) Comparison of the mode of RBD recognition by NIH-CoVnb-112 to other RBD-specific nanobodies. The NIH-CoVnb-112-RBD complex was superimposed (based on the RBD) to five published RBD complex structures of RBD-specific nanobodies, including WNb-2 (PDB: 7LDJ), VHH-E (7KN5), MR17 (7CAN), Nb12 (7MY3), and VHH-U (7KN5). The SARS-CoV-2 RBD is shown in a semi-transparent blue surface with the receptor-binding motif (RBM) highlighted in red. Other nanobodies are shown with colored lines as labeled.